Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$52.15
▼ $1.00 (-1.9%)
Market data updated: 09/19 05:39 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/19/2026
Market Cap
$11.37B
Day Range
$51.93 - $52.86
52-Week Range
$40.00 - $58.70
Beta
—
Next Earnings
09.11.2026
Support
$51.93
Resistance
$58.70
+22.3% (1Y)
Strengths: 5/25 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 244.8%
Growth
Biggest negative driver
Operating margin stability
Operating margin is eroding over time
Quality
Signal tension
Growth scores strong (68/100), but fair-value analysis scores this stock as relatively expensive (45/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
46
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
68
Quality
42
Value
45
Momentum
33
Risk
58
Sentiment
38
Fundamental
48
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **American Healthcare REIT, Inc.** has focused on strategic growth and leadership transitions. The company announced a **$696 million acquisition of eight senior housing communities**, expanding its East Coast footprint and partnering with **LCB Senior Living**, while also securing a **$2 billion-plus year-to-date investment total**. Additionally, it named **Aric Chang as CFO** (replacing retiring Brian Peay) and appointed **Jon Crosier as Chief Technology Officer**, signaling leadership and operational shifts.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about American Healthcare REIT, Inc.. News trend score: 38. Reason: 8 of the last 20 articles are negative, versus 6 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
30
🎯 Conviction (vs. Emotion)
36
Psychology
92
Fundamentals
48
Technical
33
Valuation
45
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
+12%
Market Narrative
30
Fundamental Reality
36
Narrative Gap
-6
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market’s psychology for AHR is characterized by a **narrative-reality gap** (25-point divergence), where euphoria (20) persists despite weak momentum (-1.7% ROC) and neutral RSI (45). The 6.4% premium over the 200-day average, combined with high sentiment (98/100), suggests investors may be anchoring to recent highs while ignoring technical weakness. Anchoring (9) and overconfidence (0, but implied by EPS underperformance) hint at a disconnect between price action and fundamentals. The key question: will the gap close via price correction or narrative adjustment?
Updated: 09/09/2026, 03:07 AM
What could change this?
👥 What the crowd believes
"AHR secured a 10-community opportunity and simultaneously assigned two of the properties at their allocated basis, capturing the opportunity without compromising capital allocation discipline"
"establishing a new operating relationship with LCB Senior Living and a substantial presence in supply-constrained East Coast markets"
"Aric Chang has been appointed Chief Financial Officer, effective October 1, 2026. Chang succeeds Brian Peay, who is retiring after 10 years"
"AHR’s total year-to-date investments now exceed $2 billion and the Company’s awarded investment pipeline stands at approximately $675 million"
📈 5D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 98/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 0/100
🗣️ Why do they disagree?
This stock sparks a sharp divide among historical methodologies, with some models seeing it as a high-potential opportunity while others flag it as risky or overvalued. Samuel Armstrong Nelson and Peter Lynch both rate it favorably—Nelson’s cycle analysis suggests it’s oversold, and Lynch sees it as a growth stock whose price hasn’t yet reflected its potential. However, more cautious investors like Benjamin Graham and Philip Fisher dismiss it outright, with Graham calling it a defensive failure and Fisher noting the lack of quality/growth traits he prized. Meanwhile, mid-tier approaches like Howard Marks and Morgan Housel acknowledge its risks—Marks warns of inflated expectations, while Housel describes it as ‘holdable but not effortless,’ illustrating a spectrum from bullish optimism to guarded skepticism.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 98
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 94
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 78
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 73
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 73
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 68
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 60
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 60
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 57
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 47
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 42
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 36
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 31
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 22
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 8
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 0
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Based on the last 281 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 8 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
20.6%
Operating Margin
18.4%
Net Margin
3.1%
EBITDA Margin
26.7%
ROE
2.1%
ROA
1.3%
ROIC
—
EPS
$0.42
Cash
$114.84M
Total Debt
—
Current Ratio
—
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 30.6.2026 | $0.250 |
| 29.6.2026 | $0.250 |
| 31.3.2026 | $0.250 |
| 30.3.2026 | $0.250 |
| 31.12.2025 | $0.250 |
| 30.12.2025 | $0.250 |
| 30.9.2025 | $0.250 |
| 29.9.2025 | $0.250 |
| 30.6.2025 | $0.250 |
| 29.6.2025 | $0.250 |
| 31.3.2025 | $0.250 |
| 30.3.2025 | $0.250 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$19.90
Tangible Book Value per Share (Tangible NAV)
$16.98
Sentiment based on basic keywords (not AI) — 6 positive, 6 neutral, 8 negative out of the last 20 articles.
Yahoo · 18.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
SeekingAlpha · 15.9.2026
Yahoo · 14.9.2026
Yahoo · 11.9.2026
Yahoo · 10.9.2026
Business Wire · 10.9.2026
Yahoo · 9.9.2026
Motley Fool · 9.9.2026
SeekingAlpha · 9.9.2026
Yahoo · 8.9.2026
TMX Newsfile · 8.9.2026
Yahoo · 8.9.2026
Business Wire · 8.9.2026
SeekingAlpha · 7.9.2026
MT Newswires · 3.9.2026
Yahoo · 3.9.2026
Business Wire · 3.9.2026
Benzinga · 3.9.2026
American Healthcare REIT, Inc. (AHR) currently has a StockIQ AI score of 46/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AHR currently scores 46/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
AHR's technical score is 33/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 244.8%; Net income growth: 284.6%; Calmar: 4.91 (3y annualized return 69.1% / max drawdown 14.1%).
Based on the real signals StockIQ computed: Operating margin is eroding over time; Price is below the 50-day average; MACD histogram is negative — falling momentum.
Yes — AHR has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 2 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Foster Mark E. | Open Market Sale | 1.9.2026 | 2,000 | -2,000 | $55.39 |
| Willhite Gabriel M | Grant/Award from Employer | 21.7.2026 | 6,038 | +6,038 | — |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 30,886 | +30,886 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 59,945 | -59,945 | $56.66 |
| Prosky Danny | Grant/Award from Employer | 21.7.2026 | 2,594 | +2,594 | — |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 20,912 | -20,912 | — |
| Hanson Jeffrey T | Grant/Award from Employer | 21.7.2026 | 35,981 | +35,981 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 11,283 | -11,283 | $56.66 |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 20,912 | +20,912 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 16,663 | -16,663 | $56.66 |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 30,886 | -30,886 | — |
| Hanson Jeffrey T | Grant/Award from Employer | 21.7.2026 | 35,981 | +35,981 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 286,524 | -59,945 | $56.66 |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 317,410 | +30,886 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 300,747 | -16,663 | $56.66 |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 321,659 | +20,912 | — |
| Prosky Danny | Tax Withholding in Shares | 21.7.2026 | 310,376 | -11,283 | $56.66 |
| Prosky Danny | Grant/Award from Employer | 21.7.2026 | 312,970 | +2,594 | — |
| Prosky Danny | Exercise of Derivative Securities | 21.7.2026 | 0 | -20,912 | — |
| Willhite Gabriel M | Grant/Award from Employer | 21.7.2026 | 6,038 | +6,038 | — |
| Prosky Danny | Grant/Award from Employer | 21.7.2026 | 313,592 | +2,594 | — |
| PEAY BRIAN | Open Market Sale | 26.6.2026 | 25,000 | -25,000 | $50.70 |
| Flornes Brian J. | Grant/Award from Employer | 24.6.2026 | 2,594 | +2,594 | — |
| Smith Wilbur H III | Grant/Award from Employer | 24.6.2026 | 2,594 | +2,594 | — |
| Hurley Dianne | Grant/Award from Employer | 24.6.2026 | 2,594 | +2,594 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
21,144,851 shares short as of 2026-08-31 · vs. 22,144,341 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
62.1% of trading volume this week was short selling, vs. 60.8% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology